Bioprocessing

The development of the p(BA-V4D4) copolymer provides a balance of softness for stress absorption and strength to maintain structural integrity during rapid ion movement. While most consumers associate battery degradation with a mysterious chemical expiration, the primary driver of failure in modern

The high cost of exogenous growth factors like BMP-2 remains a major financial barrier to the commercial production of living, engineered bone substitutes. For decades, the reliance on these expensive proteins has restricted high-end tissue engineering to academic research, but the landscape is

Engineering stable microbial cell factories requires genetic tools that function reliably when integrated into the chromosome rather than relying on high-copy plasmids. This foundational principle guided a recent high-impact collaboration between scientific teams in Argentina and Spain, who sought

A comparative study using a trastuzumab biosimilar revealed that automation can reduce the average variability in glycan profiling by twenty-eight percent compared to manual processing. This discovery comes at a critical time in 2026, as the pharmaceutical sector grapples with the increasing

BeneMeat’s partnership with the Italian brand FORZA10 serves as a practical case study for the commercial application of cultivated cells in the animal feed sector. This collaboration marks a significant milestone in the broader trajectory of cellular agriculture, moving beyond speculative research

Sustainability is increasingly viewed as a risk mitigation strategy rather than a simple cost center, directly enabling a site to double its capacity in the future. As the current landscape of late 2026 unfolds, the American biopharmaceutical manufacturing sector has transitioned from a period of